SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands	3 Months Ended
	Jul. 01, 2023 USD ($) segment	Jul. 02, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment	3
Net revenues before foreign exchange impact	$ 305,324	$ 258,799
Effect of exchange rates	244	(2,478)
Net revenues	311,332	261,458
Operating income	53,659	30,767
Effect of exchange rates	2,613	6,245
Restructuring Costs	11	44
Restructuring related costs	2,204	3,522
Digital transformation costs	3,705	0
Impairment of assets and PCS2 related charges	141	350
Integration and transaction costs	(1,115)	758
Amortization of acquired intangible assets	7,473	8,367
MDR and IVDR costs	(1,166)	(3,186)
Litigation-related charges	(1,058)	(196)
United States
Segment Reporting Information [Line Items]
Net revenues	237,073	181,996
Japan
Segment Reporting Information [Line Items]
Net revenues	11,773	13,878
Europe
Segment Reporting Information [Line Items]
Net revenues	39,387	40,457
Rest of Asia
Segment Reporting Information [Line Items]
Net revenues	22,040	24,424
Other
Segment Reporting Information [Line Items]
Net revenues	1,059	703
Service
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	5,764	5,137
Net revenues	5,774	4,889
Plasma
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	138,482	103,042
Net revenues	138,610	102,381
Restructuring related costs	169	640
Blood Center
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	67,306	66,573
Net revenues	67,340	65,694
Restructuring related costs	45	2
Whole Blood, Blood Center
Segment Reporting Information [Line Items]
Net revenues	20,040	19,595
Apheresis, Blood Center
Segment Reporting Information [Line Items]
Net revenues	47,300	46,099
Hospital
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	99,536	89,184
Net revenues	99,608	88,494
Restructuring related costs	49	89
Hemostasis Management, Hospital
Segment Reporting Information [Line Items]
Net revenues	37,820	33,497
Vascular Closure, Hosptial
Segment Reporting Information [Line Items]
Net revenues	37,620	29,568
Other, Hopsital
Segment Reporting Information [Line Items]
Net revenues	24,168	25,429
Business Unit
Segment Reporting Information [Line Items]
Net revenues	305,558	256,569
Operating Segments
Segment Reporting Information [Line Items]
Operating income	142,924	120,225
Operating Segments | Plasma
Segment Reporting Information [Line Items]
Operating income	75,698	55,126
Operating Segments | Blood Center
Segment Reporting Information [Line Items]
Operating income	26,283	30,377
Operating Segments | Hospital
Segment Reporting Information [Line Items]
Operating income	40,943	34,722
Corporate
Segment Reporting Information [Line Items]
Operating income	75,309	81,584
Restructuring related costs	$ 1,941	$ 2,791